Drug intelligence / Profile preview

prebiotic combination 1

Development stage: Preclinical
Lead developer: Pharmavite
Administration: Oral

Overview

Prebiotic combination 1 is a dietary supplement composed of two polysaccharides. It functions as a prebiotic, meaning it is selectively utilized by host microorganisms in the gut, conferring health benefits. The supplement remains largely undigested in the upper gastrointestinal tract and reaches the colon, where it is fermented by resident gut microbiota. This fermentation process leads to the production of beneficial metabolites, such as short-chain fatty acids, which are implicated in human health. It is being investigated for its effects on gut microbiota modulation and overall quality of life.

Beyond the preview

Go deeper on prebiotic combination 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on prebiotic combination 1.

Explore the full profile